PKR (EIF2AK2) pThr451 rabbit polyclonal antibody, Aff - Purified
Applications | IHC, WB |
Reactivities | Human |
PKR (EIF2AK2) pThr451 rabbit polyclonal antibody, Aff - Purified
Applications | IHC, WB |
Reactivities | Human |
Rabbit Polyclonal PKR Antibody
Applications | IHC, WB |
Reactivities | Human, Mouse, Rat |
Conjugation | Unconjugated |
Immunogen | PKR antibody was raised against a peptide corresponding to 14 amino acids near the amino terminus of human PKR. |
PKR (EIF2AK2) pThr446 rabbit polyclonal antibody, Aff - Purified
Applications | WB |
Reactivities | Human |
Rabbit Polyclonal PKR (Thr446) Antibody (Phospho-specific)
Applications | WB |
Reactivities | Human |
Conjugation | Unconjugated |
Immunogen | The antiserum was produced against A synthesized peptide derived from human PKR around the phosphorylation site of Threonine 446 |
Modifications | Phospho-specific |
Rabbit anti-Eif2ak2 Polyclonal Antibody
Applications | WB |
Reactivities | Human, Mouse, Rat |
Conjugation | Unconjugated |
Immunogen | Recombinant protein of human Eif2ak2 |
Rabbit Polyclonal PKR Antibody
Applications | IF, IHC, WB |
Reactivities | Human, Mouse, Rat |
Conjugation | Unconjugated |
Immunogen | PKR antibody was raised against a peptide corresponding to 14 amino acids near the carboxy terminus of human PKR. |
Rabbit polyclonal PKR (Ab-451) antibody
Applications | IHC |
Reactivities | Human, Mouse |
Conjugation | Unconjugated |
Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human PKR around the phosphorylation site of threonine 451(K-G-TP-L-R). |
Rabbit polyclonal PKR (Thr451) antibody(Phospho-specific)
Applications | IHC |
Reactivities | Human, Mouse |
Conjugation | Unconjugated |
Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human PKR around the phosphorylation site of threonine 451(K-G-TP-L-R). |
Modifications | Phospho-specific |
Anti-EIF2AK2 (Phospho-Thr446) Rabbit Polyclonal Antibody
Applications | IF, IHC, WB |
Reactivities | Human |
Conjugation | Unconjugated |
Immunogen | Peptide sequence around phosphorylation site of threonine 446 (K-R-T(p)-R-S) derived from Human PKR. |
Modifications | Phospho-specific |
Rabbit Polyclonal PKR Antibody
Applications | WB |
Reactivities | Human |
Conjugation | Unconjugated |
Immunogen | The antiserum was produced against A synthesized peptide derived from human PKR |
PKR (EIF2AK2) rabbit polyclonal antibody, Aff - Purified
Applications | IHC, WB |
Reactivities | Human |
PKR (EIF2AK2) rabbit polyclonal antibody, Aff - Purified
Applications | IHC |
Reactivities | Human |
Carrier-free (BSA/glycerol-free) EIF2AK2 mouse monoclonal antibody,clone OTI3F5
Applications | IHC, WB |
Reactivities | Human |
Conjugation | Unconjugated |
Anti-EIF2AK2 Rabbit Polyclonal Antibody
Applications | IHC |
Reactivities | Human, Mouse, Rat |
Conjugation | Unconjugated |
Immunogen | Synthetic peptide corresponding to a region derived from 438-451 amino acids of Human eukaryotic translation initiation factor 2-alpha kinase 2 |
Phospho-PKR/EIF2AK2-T446 Rabbit polyclonal Antibody
Applications | WB |
Reactivities | Human, Mouse |
Conjugation | Unconjugated |
Immunogen | A phospho specific peptide corresponding to residues surrounding T446 of human PKR/EIF2AK2 |
Modifications | Phospho T446 |
EIF2AK2 mouse monoclonal antibody,clone OTI3F5
Applications | IHC, WB |
Reactivities | Human |
Conjugation | Unconjugated |
USD 420.00
4 Weeks
EIF2AK2 mouse monoclonal antibody,clone OTI3F5, Biotinylated
Applications | IHC, WB |
Reactivities | Human |
Conjugation | Biotin |
USD 420.00
4 Weeks
EIF2AK2 mouse monoclonal antibody,clone OTI3F5, HRP conjugated
Applications | IHC, WB |
Reactivities | Human |
Conjugation | HRP |
EIF2AK2 mouse monoclonal antibody,clone OTI3F5
Applications | IHC, WB |
Reactivities | Human |
Conjugation | Unconjugated |